| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $19,196,142 | 30 | 100 |
| Quackenbush Doris | Sales VP | 0 | $0 | 1 | $168,720 | $-168,720 |
| Kemp Jens | Chief Marketing Officer | 0 | $0 | 2 | $428,294 | $-428,294 |
| THOMAS PAUL | director | 0 | $0 | 1 | $633,710 | $-633,710 |
| DeVinney Erick Wayne | Chief Innovation Officer | 0 | $0 | 2 | $780,544 | $-780,544 |
| Hartley Lindsey Marie | CFO | 0 | $0 | 3 | $942,196 | $-942,196 |
| Burke William P. Mr. | director | 0 | $0 | 4 | $951,152 | $-951,152 |
| TYNDALL JOSEPH A. | director | 0 | $0 | 2 | $951,710 | $-951,710 |
| JOHNSON JOHN | director | 0 | $0 | 3 | $1.87M | $-1.87M |
| Wendell Amy McBride | director | 0 | $0 | 3 | $2M | $-2M |
| DALE MICHAEL D | Chief Executive Officer | 0 | $0 | 2 | $2.67M | $-2.67M |
| Began Marc A | EVP & General Counsel | 0 | $0 | 3 | $3.88M | $-3.88M |
| Weiler Kathy Johnson | director | 0 | $0 | 4 | $3.92M | $-3.92M |
AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral …
Over the last 12 months, insiders at AxoGen, Inc. have bought $0 and sold $19.2M worth of AxoGen, Inc. stock.
On average, over the past 5 years, insiders at AxoGen, Inc. have bought $188,940 and sold $5.01M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $62,240 was made by Wendell Amy McBride (director) on 2023‑09‑06.
| 2026-09-02 | Sale | TYNDALL JOSEPH A. | director | 3,500 0.0067% | $49.70 | $173,940 | -12.71% | |
| 2026-08-11 | Sale | Wendell Amy McBride | director | 13,353 0.0248% | $48.42 | $646,592 | -8.13% | |
| 2026-08-10 | Sale | Began Marc A | EVP & General Counsel | 67,500 0.1243% | $47.34 | $3.2M | -7.19% | |
| 2026-08-07 | Sale | Weiler Kathy Johnson | director | 14,150 0.0259% | $45.30 | $640,967 | -3.14% | |
| 2026-05-08 | Sale | Wendell Amy McBride | director | 1,647 0.0031% | $42.60 | $70,162 | +1.64% | |
| 2026-05-07 | Sale | Quackenbush Doris | Sales VP | 3,878 0.0073% | $43.51 | $168,720 | -1.59% | |
| 2026-05-07 | Sale | Kemp Jens | Chief Marketing Officer | 4,000 0.0075% | $43.44 | $173,761 | -1.59% | |
| 2026-05-07 | Sale | Hartley Lindsey Marie | CFO | 1,051 0.002% | $43.67 | $45,897 | -1.59% | |
| 2026-05-07 | Sale | Weiler Kathy Johnson | director | 16,344 0.0312% | $44.09 | $720,623 | -1.59% | |
| 2026-05-07 | Sale | JOHNSON JOHN | director | 11,050 0.0207% | $43.26 | $477,968 | -1.59% | |
| 2026-03-16 | Sale | DeVinney Erick Wayne | Chief Innovation Officer | 5,221 0.0101% | $32.84 | $171,458 | +27.44% | |
| 2025-12-16 | Sale | Wendell Amy McBride | director | 43,684 0.0949% | $29.31 | $1.28M | +34.21% | |
| 2025-12-16 | Sale | Weiler Kathy Johnson | director | 40,073 0.0877% | $29.55 | $1.18M | +34.21% | |
| 2025-12-16 | Sale | Weiler Kathy Johnson | director | 46,653 0.1022% | $29.55 | $1.38M | +34.21% | |
| 2025-12-15 | Sale | Hartley Lindsey Marie | CFO | 14,812 0.0323% | $29.86 | $442,294 | +32.24% | |
| 2025-12-11 | Sale | Began Marc A | EVP & General Counsel | 13,222 0.0288% | $30.00 | $396,660 | +31.12% | |
| 2025-12-10 | Sale | DALE MICHAEL D | Chief Executive Officer | 25,000 0.0533% | $30.00 | $750,000 | +30.79% | |
| 2025-12-09 | Sale | DeVinney Erick Wayne | Chief Innovation Officer | 19,517 0.0433% | $31.21 | $609,087 | +27.44% | |
| 2025-12-09 | Sale | DALE MICHAEL D | Chief Executive Officer | 61,463 0.1364% | $31.21 | $1.92M | +27.44% | |
| 2025-12-09 | Sale | Kemp Jens | Chief Marketing Officer | 8,156 0.0181% | $31.21 | $254,532 | +27.44% |
| Wendell Amy McBride | director | 107976 0.1808% | $5.34M | 4 | 5 | <0.0001% |
| Burke William P. Mr. | director | 100 0.0002% | $4,950.00 | 1 | 10 | +9.66% |
| Mandato Joseph M | director | 1226773 2.0538% | $60.73M | 1 | 4 | +61.29% |
| Zaderej Karen L. | CEO | 1124565 1.8827% | $55.67M | 9 | 8 | +15.63% |
| Hopfenspirger Larry | 10 percent owner | 426066 0.7133% | $21.09M | 1 | 0 | |
| Gold Mark Stephen | director | 348761 0.5839% | $17.26M | 5 | 1 | +18.2% |
| Freitag Gregory Gene | director | 271594 0.4547% | $13.44M | 6 | 12 | +24.07% |
| Harper John Frederick | director | 214094 0.3584% | $10.6M | 2 | 0 | +16.33% |
| Engels John P | VP | 98425 0.1648% | $4.87M | 1 | 0 | +19.13% |
| NEELS GUIDO J | director | 86743 0.1452% | $4.29M | 1 | 2 | +24.78% |
| MARIANI PETER J | EVP & Chief Financial Officer | 63603 0.1065% | $3.15M | 1 | 9 | +19.13% |
| MCCARREY SHAWN F | SVP Sales | 33057 0.0553% | $1.64M | 3 | 1 | +6.14% |
| Johnston Lee Robert Jr | Chief Finacial Officer | 25000 0.0419% | $1.24M | 3 | 0 | +32.93% |
| Rudelius Robert James | director | 23273 0.039% | $1.15M | 3 | 1 | |
| Blackford Quentin S. | director | 15535 0.026% | $768,982.50 | 2 | 0 | <0.0001% |
| Schiaparelli Jill F | SVP, Bus. Strategy&Marketing | 12750 0.0213% | $631,125.00 | 6 | 0 | +14.98% |
| Billet Isabelle | Chief Strategy and BD Officer | 9496 0.0159% | $470,052.00 | 1 | 1 | <0.0001% |
| MARTINEZ MARIA D. | Chief Human Resources Officer | 2932 0.0049% | $145,134.00 | 1 | 2 | <0.0001% |
| Leach Kevin | Vice President Marketing | 2000 0.0033% | $99,000.00 | 1 | 0 | +19.13% |
| Increased Positions | 124 | +65.61% | 8M | +19.08% |
| Decreased Positions | 84 | -44.44% | 6M | -15.26% |
| New Positions | 54 | New | 4M | New |
| Sold Out Positions | 18 | Sold Out | 595,699 | Sold Out |
| Total Postitions | 229 | +21.16% | 43M | +3.82% |
| First Light Asset Management, Llc | $179,978.00 | 12.62% | 5.81M | +1M | +28.18% | 2025-09-30 |
| Blackrock, Inc. | $111,884.00 | 7.85% | 3.61M | +108,868 | +3.11% | 2025-09-30 |
| Vanguard Group Inc | $83,061.00 | 5.83% | 2.68M | -51,003 | -1.87% | 2025-09-30 |
| Morgan Stanley | $75,325.00 | 5.28% | 2.43M | -80,862 | -3.22% | 2025-09-30 |
| Arrowmark Colorado Holdings Llc | $60,711.00 | 4.26% | 1.96M | +332,498 | +20.45% | 2025-09-30 |
| Soleus Capital Management, L.P. | $53,523.00 | 3.75% | 1.73M | +267,158 | +18.31% | 2025-09-30 |
| Wasatch Advisors Lp | $50,820.00 | 3.56% | 1.64M | +205,569 | +14.34% | 2025-09-30 |
| Balyasny Asset Management L.P. | $42,769.00 | 3% | 1.38M | -551,516 | -28.56% | 2025-09-30 |
| Assenagon Asset Management S.A. | $39,961.00 | 2.8% | 1.29M | +265,950 | +25.99% | 2025-09-30 |
| Armistice Capital, Llc | $37,200.00 | 2.61% | 1.2M | +88,681 | +7.98% | 2025-09-30 |